Predicting Psychotropic Drug Orexigenic Potential via AMPK Phosphorylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antipsychotic drugs (AAPDs) used to treat schizophrenia often cause weight gain due to increased food intake, leading to side effects like metabolic alterations and reduced patient compliance, with limited understanding of the underlying mechanisms.
Innovation Solution
Developing methods to predict whether a psychotropic drug will be orexigenic by testing its interaction with histamine H1 receptors and hypothalamic AMPK, including using isogenic pairs of cells to assess AMPK activity, which helps identify drugs with fewer adverse effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If atypical antipsychotic drugs are used to treat schizophrenia, then negative symptoms improve and fewer side effects occur compared to classic neuroleptics, but pronounced weight gain occurs predominantly mediated by increased food intake
Solution Approach 1:
The patent applies preliminary action by measuring AMPK phosphorylation levels before clinical treatment begins. This pre-assessment allows identification of patients at high risk for drug-induced weight gain, enabling proactive intervention strategies such as lifestyle modifications, prophylactic medications, or selection of alternative antipsychotic agents before weight gain occurs
Solution Approach 2:
The patent uses AMPK phosphorylation status as an intermediary biomarker to mediate between antipsychotic drug administration and weight gain outcomes. By measuring this molecular indicator, the system predicts weight gain risk and guides clinical decision-making, effectively using AMPK status as a mediator to prevent harmful effects while maintaining treatment benefits
2Object-generated harmful factors
If AMPK activation is increased to reduce food intake and weight gain, then lipid formation decreases and food intake is reduced, but the mechanism requires precise hypothalamic regulation which is complex to modulate
Solution Approach 1:
The patent replaces complex mechanical hypothalamic regulation with a simplified biochemical assay measuring AMPK phosphorylation levels. Instead of directly manipulating hypothalamic circuits and neuronal pathways, the invention uses a biochemical marker (phosphorylated AMPK) that can be measured in peripheral or easily accessible tissues, substituting a complex neural control system with a measurable molecular indicator
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed method effectively predicts orexigenic potential of psychotropic drugs, allowing for the development of agents with reduced weight gain and metabolic side effects, thereby improving patient compliance and understanding of hypothalamic regulation of food intake.
Implementation Method 1
one determines if the agent binds to the H1R or inhibits histamine binding to the H1R
Implementation Method 2
AMPK activation is associated with decreased lipid formation, as AMPK phosphorylates acetyl-CoA carboxylase (ACC) inhibiting the generation of malonyl-CoA
Implementation Method 3
inhibiting the generation of malonyl-CoA. Malonyl-CoA is a substrate for fatty acid synthase so that inhibition of ACC diminishes formation of fatty acids and lipid
Implementation Method 4
one determines if the agent increases phosphorylation or increases activity of the AMPK
Data Source
AI summary
The atypical antipsychotic drugs (AAPDs) have markedly enhanced the treatment of schizophrenias but their use has been hindered by the major weight gain elicited by some AAPDs. We found that orexigenic AAPDs potently and selectively activate hypothalamic AMP kinase (AMPK), an action abolished in mice with deletion of histamine H1 receptors. These findings afford a means of developing better therapeutic agents and provide insight into the hypothalamic regulation of food intake.